Research ArticleAccepted Article
Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García and Laura Sampietro-Colom
The Journal of Rheumatology November 2019, jrheum.190533; DOI: https://doi.org/10.3899/jrheum.190533
Luca Moroni
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Gabriela Restovic
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Ricard Cervera
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Gerard Espinosa
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Odette Viñas
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Milagros García
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
Laura Sampietro-Colom
From the Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan, Italy; Fundació Clínic per la Recerca Biomèdica, Barcelona, Catalonia, Spain; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Department of Immunology, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain. Corresponding author: Ricard Cervera, MD, PhD, FRCP, Department of Autoimmune Diseases, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Catalonia, Spain. e-mail: rcervera@clinic.cat
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García, Laura Sampietro-Colom
The Journal of Rheumatology Nov 2019, jrheum.190533; DOI: 10.3899/jrheum.190533
Accepted manuscript
Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García, Laura Sampietro-Colom
The Journal of Rheumatology Nov 2019, jrheum.190533; DOI: 10.3899/jrheum.190533